Literature DB >> 11015369

Rapid differentiation of fermentative from nonfermentative gram-negative bacilli in positive blood cultures by an impedance method.

T C Chang1, A H Huang.   

Abstract

Rapid differentiation of fermentative gram-negative bacilli (fermenters) from nonfermentative gram-negative bacilli (nonfermenters) in positive blood cultures may help physicians to narrow the choice of appropriate antibiotics for empiric treatment. An impedance method for direct differentiation of fermenters from nonfermenters was investigated. The bacterial suspensions (or positive culture broths containing gram-negative bacteria) were inoculated into the module wells of a Bactometer (bioMérieux, Inc., Hazelwood, Mo.) containing 1 ml of Muller-Hinton broth. The inoculated modules were incubated at 35 degrees C, and the change in impedance in each well was continuously monitored. The amount of time required to cause a series of significant deviations from baseline impedance values was defined as the detection time (DT). The percent change of impedance was defined as the change of impedance at the time interval from DT to DT plus 1 h. After testing 857 strains of pure cultures (586 strains of fermenters and 271 strains of nonfermenters), a breakpoint (2.98%) of impedance change was obtained by discriminant analysis. Strains displaying impedance changes of greater than 2.98% were classified as fermenters; the others were classified as nonfermenters. By using this breakpoint, 98.6% (340 of 345) of positive blood cultures containing fermenters and 98% (98 of 100) of positive blood cultures containing nonfermenters were correctly classified. The impedance method was simple, and the results were normally available within 2 to 4 h after direct inoculation of positive blood culture broths.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11015369      PMCID: PMC87442     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features.

Authors:  J M Cisneros; M J Reyes; J Pachón; B Becerril; F J Caballero; J L García-Garmendía; C Ortiz; A R Cobacho
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

2.  Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis.

Authors:  J M Gatell; A Trilla; X Latorre; M Almela; J Mensa; A Moreno; J M Miro; J A Martinez; M T Jimenez de Anta; E Soriano
Journal:  Rev Infect Dis       Date:  1988 Jan-Feb

3.  A 25-year study of nosocomial bacteremia in an adult intensive care unit.

Authors:  J D Edgeworth; D F Treacher; S J Eykyn
Journal:  Crit Care Med       Date:  1999-08       Impact factor: 7.598

4.  Combination effect of ceftriaxone with four aminoglycosides on nonfermenting gram-negative bacteria.

Authors:  H M Just; A Beckert; M Bassler; F D Daschner
Journal:  Chemotherapy       Date:  1982       Impact factor: 2.544

Review 5.  Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality.

Authors:  H Seifert; A Strate; G Pulverer
Journal:  Medicine (Baltimore)       Date:  1995-11       Impact factor: 1.889

6.  Clinical impact of rapid in vitro susceptibility testing and bacterial identification.

Authors:  G V Doern; R Vautour; M Gaudet; B Levy
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

7.  Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam.

Authors:  P C Appelbaum; J Tamim; G A Pankuch; R C Aber
Journal:  Chemotherapy       Date:  1983       Impact factor: 2.544

8.  Pseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodes.

Authors:  J Bisbe; J M Gatell; J Puig; J Mallolas; J A Martinez; M T Jimenez de Anta; E Soriano
Journal:  Rev Infect Dis       Date:  1988 May-Jun

9.  Susceptibility of 310 nonfermentative gram-negative bacteria to aztreonam, carumonam, ciprofloxacin, ofloxacin and fleroxacin.

Authors:  P C Appelbaum; S K Spangler; T Tamarree
Journal:  Chemotherapy       Date:  1988       Impact factor: 2.544

10.  Combination effect of piperacillin with four aminoglycosides on nonfermenting gram-negative bacteria.

Authors:  F Daschner; H Langmaack; M Grehn; A Steffens; M Just
Journal:  Chemotherapy       Date:  1981       Impact factor: 2.544

View more
  2 in total

Review 1.  Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy.

Authors:  Anthony A Adegoke; Thor A Stenström; Anthony I Okoh
Journal:  Front Microbiol       Date:  2017-11-30       Impact factor: 5.640

Review 2.  Rapid clinical bacteriology and its future impact.

Authors:  Alex van Belkum; Géraldine Durand; Michel Peyret; Sonia Chatellier; Gilles Zambardi; Jacques Schrenzel; Dee Shortridge; Anette Engelhardt; William Michael Dunne
Journal:  Ann Lab Med       Date:  2012-12-17       Impact factor: 3.464

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.